Wednesday, the CDC recommended an additional dose of the updated COVID booster for adults 65 and older at least four months after their first updated booster. Many of us received that back in the fall and the concern is that immunity has waned since then, and an additional dose can p...
Editor's note: Find the latest COVID-19 news and guidance in Medscape'sCoronavirus Resource Center. A US Food and Drug Administration (FDA) advisory panel voted unanimously today to recommend a booster dose of Pfizer's mRNA COVID-19 vaccine for those 65 and older, and for those at high ...
The most significant change, however, concerned France’s Covid booster vaccine scheme. Macron announced that from December 15th, over-65s must have a booster in order to access the Health Pass (Pass Sanitaire). Boosters are currently available for all over 65s, as well as for those wit...
France is averaging around 20,000 new COVID-19 cases a day, with the return of schools next week after the summer holidays raising concern about a new surge in infections. The World Health Organization has called for a moratorium on booster shots until at least the end of September in orde...
Food and Drug Administration (FDA) endorsed on Friday a booster dose of the Pfizer-BioNTech COVID-19 vaccine six months after full vaccination in people 65 and older and for individuals at high risk for severe disease. The decision came after members of the FDA's Vaccines and Related ...
STOCKHOLM (AP) — Sweden is recommending a fifth COVID-19 vaccine dose for people with an increased risk of becoming seriously ill, including pregnant women and anyone aged 65 and over, authorities said Tuesday, adding that the country must "be prepared
辉瑞(Pfizer)与BioNTech近日宣布,已向美国食品和药物管理局(FDA)提交了COVID-19 mRNA疫苗Comirnaty(BNT162b2)的紧急使用授权(EUA)申请:将Comirnaty作为一剂额外加强针,用于已接种任何已获许可或已获批准COVID-19疫苗初始加强针的65岁...
Pending that data, he said, the company could file for annual COVID-19 vaccinations before next year's flu season. U.S. regulators recently authorized a round of booster doses for certain age and risk groups for the Pfizer/BioNTech, Moderna and Johnson & Johnson vaccin...
People 65 and older account for 16% of the total US population but 75% of all COVID deaths to date. Vaccinations, boosters, and treatments have led to a substantial decline in severe disease, hospitalizations, and deaths from COVID-19, but with booster uptake lagging, deaths for older adul...
FDA authorizes booster doses for Americans aged 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19. FDA building, Wash. D.C.iStock The US Food and Drug Administration on Wednesday authorized booster doses of COVID-19 ...